Novavax soars 39.6% in premarket after Sanofi license deal



The shares of Novavax Inc. surged in the premarket trading session in the United States on Friday following the announcement it will enter into a co-exclusive agreement with Sanofi to commercialize th…
About the author:

Get involved!

Fai trading in gruppo!
L'unica Academy di trading completamente gratuita per gli utenti FpMarkets

Comments

Ancora nessun commento